$27-million Medicine by Design investment will fast-track stem cell research

Peter Zandstra at the Canada First Research Excellence Fund announcement last year (Johnny Guatto photo)

David McMillen and his team are hard at work designing a new custom-designed probiotic to help the 233,000 Canadians living with Crohn’s and colitis.

The goal of the project, which is among 20 sharing $27 million in funding from university’s newly created Medicine by Design initiative, is to create a bacterium that can help trigger the renewal of the gut lining in people with these chronic bowel diseases.

Continue reading at UofT News.